News - Dermatologicals, Licensing

Filter

Current filters:

DermatologicalsLicensing

Popular Filters

1 to 25 of 28 results

Sandoz in deal to commercialize Anacor’s Kerydin in USA

Sandoz in deal to commercialize Anacor’s Kerydin in USA

22-07-2014

USA-based Anacor Pharmaceuticals has entered into an exclusive agreement with Sandoz, a subsidiary of…

Anacor PharmaceuticalsBusiness FinanceDermatologicalsKerydinLicensingMajorNovartisOnychomycosisPharmaceuticalPharmaceutical industryPharmaDermSandozTopical solutionUSA

LEO Pharma strikes global dermatology deal with KLOK Tech

LEO Pharma strikes global dermatology deal with KLOK Tech

16-07-2014

Danish dermatology specialist LEO Pharma and Canada’s KLOX Technologies, both privately-held companies,…

Acne vulgarisDermatologicalsGlobalKLOX TechnologiesLEO PharmaLicensingPharmaceutical

UCB and Dermira link up for Cimzia in dermatology

UCB and Dermira link up for Cimzia in dermatology

03-07-2014

Belgium’s largest drugmaker UCB and Dermira, a privately held USA-based dermatology company, have entered…

CanadaCimziaDermatologicalsDermiraEuropeLicensingPharmaceuticalResearchUCBUSA

KYTHERA regains rights to ATX-101 outside USA and Canada from Bayer

KYTHERA regains rights to ATX-101 outside USA and Canada from Bayer

11-03-2014

US biotech firm KYTHERA Biopharmaceuticals says it has re-acquired all rights outside of the USA and…

ATX-101BayerDermatologicalsKYTHERA BiopharmaceuticalsLicensingNorth AmericaPharmaceutical

Allergan closes $65 million deal with Medytox

Allergan closes $65 million deal with Medytox

09-01-2014

This week US drugmaker Allergan (NYSE: AGN) announced that it has closed a $65 million license agreement…

AllerganAsia-PacificBotoxDermatologicalsLicensingMedytoxPharmaceuticalRegulationUKUSA

Royalty Pharma acquires additional interest in Tecfidera for $510 million

Royalty Pharma acquires additional interest in Tecfidera for $510 million

06-01-2014

US private equity firm Royalty Pharma says that it has acquired an additional interest in the earn-out…

Biogen IdecDermatologicalsFumadermFumapharmLicensingNeurologicalPharmaceuticalRoyalty PharmaTecfidera

Kyowa Hakko and LEO Pharma partner on topical calcipotriol/betamethasone dipropionate in Japan

26-12-2013

Japanese drugmaker Kyowa Hakko Kirin and Denmark’s privately-held dermatology specialist LEO Pharma…

Asia-PacificBetamethasone DipropionatecalcipotriolDermatologicalsKyowa Hakko KirinLEO PharmaLicensingMarkets & MarketingPharmaceutical

APR and Angelini partner on wound management product

20-12-2013

Privately-held Italian drugmaker Angelini and Switzerland-based health care group Applied Pharma Research…

AmuphaseAngeliniApplied Pharma ResearchDermatologicalsEuropeLicensingNexodynPharmaceutical

Galapagos in deal with Biogen Idec for scleroderma research

Galapagos in deal with Biogen Idec for scleroderma research

13-11-2013

Belgian biotech firm Galapagos says that a subsidiary has signed a three-year collaboration agreement…

Biogen IdecBiotechnologyDermatologicalsGalapagosLicensingResearch

Karo Bio gets first milestone in Pfizer collaboration

06-09-2013

Under its collaboration with US pharma behemoth Pfizer (NYSE: PFE), Sweden's Karo Bio (STO: KARO) says…

Anti-Arthritics/RheumaticsDermatologicalsFinancialKaro BioLicensingNeurologicalPfizerPharmaceuticalResearch

NovaBiotics enters co-development agreement for Novexatin

28-08-2013

Scotland-headquartered clinical-stage biotech firm NovaBiotics has entered into an exclusive agreement…

BiotechnologyDermatologicalsLicensingNovaBioticsNovexatinTaro Pharmaceuticals

Mayne Pharma signs up deals to market Subacap in Europe

12-08-2013

Australian drugmaker Mayne Pharma (ASX: MYX) says it has signed two marketing and distribution agreements…

DermatologicalsEuropeGlenmark PharmaceuticalsIsdinitraconazoleLicensingMarkets & MarketingMayne PharmaPharmaceuticalSubacap

Galen in upfront $4.5million deal with Novo Research for US rights for Synera pain relief patch

11-07-2013

Canada's Nuvo Research (TSX: NRI) today (July 11) announced that its wholly owned subsidiary, ZARS Pharma,…

DermatologicalsGalen USLicensingNorth AmericaNuvo ResearchPharmaceuticalSyneraZARS Pharma

Ferrer's Ozenoxacin shows superiority in Ph III impetigo trial

05-06-2013

Privately-held Spanish drugmaker Ferrer Internacional says that it has successfully completed a Phase…

Antibiotics and Infectious diseasesDermatologicalsFerrer InternacionalLicensingOzenoxacinPharmaceuticalResearch

LEO Pharma and 4SC Discovery link for skin disease research

26-02-2013

Privately-held Danish dermatology specialist LEO Pharma has entered into an exclusive research and license…

4SC DiscoveryBiotechnologyDermatologicalsLEO PharmaLicensingPharmaceuticalResearch

PharmaEssentia gets certain Asian rights to Kinex' dermatology candidate KX01

03-12-2012

USA-based privately-held Kinex Pharmaceuticals has entered a licensing agreement granting Taiwan's PharmaEssentia…

Asia-PacificBiotechnologyDermatologicalsKinex PharmaceuticalsKX01LicensingPharmaEssentia

Kyorin Pharma transfers Pekiron rights to Galderma

11-10-2012

Japan's Kyorin Holdings (TYO: 4569), through its Kyorin Pharmaceuticals subsidiary, aiming to concentrate…

Asia-PacificDermatologicalsGaldermaKyorin PharmaceuticalsLicensingPekironPharmaceutical

Sinclair IS partners with Quintiles to commercialize portfolio in Mexico

13-09-2012

UK-based Sinclair IS Pharma (AIM: SPH.L) yesterday announced the signing of a 10-year collaboration and…

DermatologicalsLicensingMarkets & MarketingPharmaceuticalQuintilesSinclair IS PharmaSouth America

Nuvo Research gets $6.0 million milestone on Pliaglis EU approvals

23-07-2012

Canada-based specialty pharma firm Nuvo Research (TSX: NRI) announced that global commercial partner…

DermatologicalsEuropeFinancialGaldermaLicensingNuvo ResearchPharmaceuticalPliaglis

LEO Pharma seeks new partners to boost derma products pipeline

18-06-2012

Privately-held Danish drugmaker LEO Pharma last week revealed that it is now actively searching for new…

DermatologicalsLEO PharmaLicensingPharmaceutical

GlaxoSmithKline gets global rights to Basilea's Toctino

12-06-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) says that its dermatology-focussed subsidiary Stiefel has…

Basilea PharmaceuticaceftobiproleDermatologicalsGlaxoSmithKlineisavuconazoleLicensingPharmaceuticalResearchStiefelToctino

Hi-Tech Pharmacal gains rights to the Cormax brand from Watson

05-06-2012

Hi-Tech Pharmacal (Nasdaq: HITK) says it has signed a definitive agreement under which it has acquired…

CormaxDermatologicalsGenericsHi-Tech PharmacalLicensingWatson Pharmaceuticals

RegeneRx explores strategic options

02-02-2012

US biotech firm RegeneRx Biopharmaceuticals. (OTC Bulletin Board: RGRX) revealed yesterday that it has…

BiotechnologyCardio-vascularDermatologicalsLicensingNeurologicalOphthalmicsRegeneRx

1 to 25 of 28 results

Back to top